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Although the profiles are flat in the
viable epidermis, they demonstrate
slight changes toward the SC surface.
These changes are consistent between
the age groups and body sites tested,
and they can be explained by the enzy-
matic proteolysis of filaggrin and similar
molecules.
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TO THE EDITOR
Melanoma is a considerable public
health burden, with an estimated
76,690 new diagnoses and 9,480 deaths
from melanoma in the United States in
2013 alone (Howlader et al., 2013).
Multiplex families have pointed to
important genetic factors for mela-
noma, including high-penetrance risk
loci such as CDKN2A or CDK4
(Gruber and Armstrong, 2006). In
sporadic disease, genome-wide associ-
ation studies (GWAS) have also success-
fully identified at least eight single
nucleotide polymorphisms (SNPs)
associated with melanoma (Gerstenblith
et al., 2010). Our study aimed to
replicate these existing GWAS findings
within the large Population Architecture
using Genomics and Epidemiology
(PAGE) study in order to further evalu-
ate their association with melanoma.
In addition to genetic factors,
other risk factors for melanoma include
exposure to natural and artificial UVR,
larger numbers of nevi, pigmentation
traits (light versus dark hair, eye,
and skin color), race/ethnicity (European
versus non-European ancestry), skin
response to UV exposure (burn versus
tan), older age, and male sex (Gruber
and Armstrong, 2006). Anatomic loca-
tion of melanoma also tends to vary
by sex, arising most commonly on the
back, abdomen, and chest in males, and
on the lower leg, hip, and thigh in
females (Gruber and Armstrong, 2006).
Females also appear to have lower risk of
metastases and longer melanoma-specific
survival than males (Joosse et al., 2011).Accepted article preview online 30 January 2014; published online 27 February 2014
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As melanoma risk, anatomic location,
and survival have been shown to vary
by sex, this study also aimed to evaluate
whether genetic associations with
melanoma differed by sex as well.
To answer these questions, we eval-
uated 2,131 invasive melanoma cases
and 20,353 melanoma-free controls
from five study populations (Supplemen-
tary Table S1 online). Three studies
collaborated through their participa-
tion in the PAGE study (Matise et al.,
2011): the Multiethnic Cohort (MEC),
the Women’s Health Initiative (WHI),
and Epidemiological Architecture for
Genes Linked to Environment (EAGLE),
accessing BioVU, the Vanderbilt bio-
repository linked to de-identified elec-
tronic medical records. Two non-PAGE
studies also contributed: the Nurses’
Health Study (NHS) and the Health
Professionals Follow-up Study (HPFS).
Additional details for these studies
are provided in the Supplementary
Materials online. All analyses were per-
formed using Stata version 13 (StataCorp
LP, College Station, TX).
Study-specific logistic regression esti-
mates evaluated the association bet-
ween each SNP and melanoma, coded
additively for each copy of the pur-
ported risk allele. These results were
combined using fixed effect inverse-
weighted meta-analysis to obtain overall
effect estimates. The association bet-
ween a SNP and melanoma was consi-
dered statistically significant if the
Bonferroni-corrected P-value was below
0.006 (¼ 0.05/8). In order to evaluate
for potential sex-specific genetic effects,
we also evaluated the association bet-
ween each SNP and melanoma risk
stratified by sex. We performed meta-
regression to obtain P-heterogeneity
values for the difference between sex-
specific regression estimates, using a sta-
tistical significance threshold of P-hetero-
geneityo0.05. All participants were of the
European ancestry. HPFS is a male-only
study. As NHS and WHI are female-only
studies, the overall analysis included
roughly twice as many females as males
(Supplementary Table S1 online). Mela-
noma cases tended to be of similar or
younger age than controls (overall mean
age of 61 in cases vs. 63 in controls),
except for in EAGLE-BioVU where con-
trols were older (mean age 64 in cases
vs. 56 in controls).
We evaluated eight SNPs previously
identified by GWAS for an association
with melanoma risk (Brown et al., 2008;
Fernandez et al., 2008; Bishop et al.,
2009; Falchi et al., 2009; Gerstenblith
et al., 2010). These SNPs are in or
near genes that are likely to be impor-
tant to melanoma pathways through
their potential impact on melano-
genesis (TYR, SLC45A2/MATP, AFG3L1P/
MC1R, PIGU/ASIP), cell cycle regulation
(CDK10), cell growth, and apoptosis
(PLA2G6), or tumor suppression (MTAP/
CDKN2A). Results from the meta-
analyses across 3–5 studies showed seven
SNPs statistically significantly associated
with melanoma at Bonferroni-corrected
levels (meta-analysis Po0.006), whereas
the eighth SNP was nominally signifi-
cant (P¼0.02; Table 1). All eight
SNPs showed an association in the same
direction and of similar magnitude as
previously reported. Six of the seven
significant SNPs showed a modest
increase in melanoma risk (odds ratio
(OR)¼ 1.17–1.55), whereas rs16891982
showed a much larger effect (OR¼3.11).
Sex-stratified analyses showed similar
results, with four SNPs significantly
associated with melanoma in both
male-only and female-only meta-
analyses at Bonferroni-corrected levels,
and three SNPs nominally associated in
each (meta-analysis Po0.05; Supple-
mentary Table S2 online). Only one
of these SNPs, rs16891982, showed
a potential difference in effect by sex
(P-heterogeneity¼0.02), with a stronger
association in males (OR¼5.50, 95%
confidence interval (CI): 2.94–10.28)
than females (OR¼2.37, 95% CI: 1.69–
3.31; Table 2, Supplementary Figure S1
online). This non-synonymous SNP in
the SLC45A2 gene has previously been
associated with melanoma (Fernandez
et al., 2008; Guedj et al., 2008; Duffy
et al., 2010) and pigmentation traits
such as skin and hair color (Stokowski
et al., 2007). Also known as MATP,
this gene encodes an ion transporter
protein in the melanosome. Ion and
small-molecule transport is functio-
nally important to melanogenesis and
the pigmentation pathway (Scherer and
Kumar, 2010), as ion exchange is
predicted to impact melanogenesis by
playing an important role in regulating
melanosome pH levels (Kondo and
Hearing, 2011).
Providing biological plausibility for
a potential sex difference, in effect at
Table 1. Meta-analysis results for the association between eight melanoma GWAS SNPs and melanoma
SNP Gene Chromosome/risk allele n No. of studies OR 95% CI P-value Study P-heterogeneity
rs258322 CDK10 16/A 22,082 5 1.55 (1.41–1.70) 8.54E-19 0.62
rs4785763 AFG3L1P (near MC1R) 16/A 21,993 5 1.31 (1.22–1.40) 1.01E-14 0.73
rs16891982 SLC45A2 (MATP) 5/G 15,949 3 3.11 (2.31–4.18) 7.39E-14 0.43
rs1393350 TYR 11/A 22,009 5 1.25 (1.17–1.35) 6.21E-10 0.80
rs4636294 MTAP (near CDKN2A) 9/A 22,053 5 1.18 (1.11–1.27) 5.51E-07 0.18
rs7023329 MTAP (near CDKN2A) 9/A 22,114 5 1.17 (1.10–1.25) 1.93E-06 0.36
rs910873 PIGU (near ASIP) 20/A 15,937 3 1.31 (1.15–1.48) 2.46E-05 1.00
rs2284063 PLA2G6 22/G 22,087 5 1.09 (1.01–1.16) 0.019 0.27
Abbreviations: CI, confidence interval; OR, odds ratio; SNP, single nucleotide polymorphism.
Bold P-values are statistically significant for replication at a Bonferroni-corrected threshold of 0.05/8¼ 0.006. SNPs rs16891982 and rs910873 were not
available in Health Professionals Follow-up Study (HPFS) or Nurses’ Health Study (NHS). SNPs are ordered by P-value.
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this SNP, is the evidence that skin pig-
mentation processes can be up or down-
regulated by sex hormones. In a recent
study of the hyperpigmentation condi-
tion melasma, findings supported the
role of several ion transporters, includ-
ing SLC26A3, in the estrogen-induced
expression of tyrosinase (Kim et al.,
2012). In another study, androgens were
shown to have an inhibitory effect on
tyrosinase activity (Tadokoro et al., 2003).
Tyrosinase is considered the rate-limiting
enzyme in melanin synthesis, and regu-
lation of its activity can influence skin
pigmentation through the levels of
eumelanin and phenomelanin produced
(Kondo and Hearing, 2011). Importantly,
both tyrosinase levels and tyrosinase
activity have also been associated with
rs16891982 genotype (Cook et al., 2009).
As males and females differ in their
circulating levels of sex hormones, it is
possible that these hormones impact ion
exchange or tyrosinase activity in a way
that modifies the effect of this SLC45A2
variant on melanoma risk, perhaps
through alterations to melanogenesis
or skin pigmentation. Interestingly, sex
differences in the genetic effect of solute
carrier genes have also been seen for
other phenotypes, such as LYPLAL1/
SLC30A10 with waist–hip ratio (Randall
et al., 2013). Further research is needed
to evaluate these potential sex differences
in genetic contributions to melanoma
risk.
This study was strengthened by the
collaboration of five large studies,
which provide sizable samples to eval-
uate the melanoma GWAS SNP asso-
ciation with melanoma. Limitations
included two SNPs that were not avail-
able in HPFS and NHS (rs16891982 and
rs910873), though both still replicated.
An additional limitation is that we were
unable to test whether some of our
findings are independently associated
with melanoma, or are due to an asso-
ciation with pigmentation characteris-
tics. Additional work will be needed to
explore the relationships between these
genetic variants, pigmentation charac-
teristics, and melanoma.
In summary, this large meta-analysis
of five studies successfully replicated
seven of eight previous melanoma find-
ings, with the eighth SNP still showing a
suggestive effect in the expected direc-
tion. In addition, we observed potential
differences in effect by sex for SNP
rs16891982 in SLC45A2, with a larger
effect in males than females. This study
reinforces previous evidence that these
genetic variants are important for mela-
noma risk, and for one SNP provides
suggestive evidence for a potential
sex difference in effect. These results
implicate a complex interaction bet-
ween genetic variants, ion transport,
hormones, and pigmentation on mela-
noma etiology, and demonstrate the
potential utility of evaluating sex-
specific associations to further elucidate
these relationships.
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Challenging the Central Dogma of Skin Photobiology: Are
Proteins More Important than DNA?
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TO THE EDITOR
I read with interest the paper by Gueranger
et al. (2013) who showed that a fully
functional DNA repair proteome is a
crucial prerequisite for the removal of
harmful DNA lesions after exposure of
the skin to UVR. The authors elegantly
show that oxidative protein damage
induced by UVR precedes DNA damage,
ultimately resulting in compromised DNA
break-rejoining, base, and nucleotide exci-
sion repair. Because DNA repair pathways
consist of repair proteins (Lagerwerf et al.,
2011), it is not surprising that loss-
of-function of key DNA repair proteins
may have serious consequences in terms
of genome stability. The paper by
Gueranger et al. (2013) is extremely
interesting because it challenges the
current central dogma of photobiology,
stating that molecular alterations to DNA
have the central role in UVR-induced cell
damage and skin carcinogenesis (Nakanishi
et al., 2009; Elmets and Athar, 2013).
In accordance with the hypothesis that
proteins—and not DNA—are the mainAccepted article preview online 3 February 2014; published online 6 March 2014
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